Clinical Trial
[Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy]
[Article in
French]
- PMID: 387141
Item in Clipboard
Clinical Trial
[Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy]
[Article in
French]
Bull Int Union Tuberc.
1978 Dec.
No abstract available
Similar articles
-
[3d study by the African and British Medical Research Councils of short term chemotherapy (including relapse rates during 18 months following chemotherapy)].Bull Int Union Tuberc. 1978 Dec;53(4):254-5. Bull Int Union Tuberc. 1978. PMID: 387137 Clinical Trial. French. No abstract available.
-
[Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].Kekkaku. 1990 Dec;65(12):791-803. Kekkaku. 1990. PMID: 2077255 Japanese.
-
[New aspects of short-term chemotherapy of tuberculosis].Prax Klin Pneumol. 1983 Oct;37 Suppl 1:473-6. Prax Klin Pneumol. 1983. PMID: 6359126 Clinical Trial. German. No abstract available.
-
[Short course chemotherapy and relapse in pulmonary tuberculosis in Japan].Kekkaku. 1992 Aug;67(8):555-63. Kekkaku. 1992. PMID: 1405185 Review. Japanese.
-
[Short term treatment of infantile pulmonary tuberculosis].An Esp Pediatr. 1989 Aug;31(2):110-3. An Esp Pediatr. 1989. PMID: 2696390 Review. Spanish.
Cited by
-
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566. Clin Infect Dis. 2016. PMID: 27621353 Free PMC article.
-
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.J Clin Microbiol. 2010 Dec;48(12):4370-6. doi: 10.1128/JCM.00757-10. Epub 2010 Oct 6. J Clin Microbiol. 2010. PMID: 20926712 Free PMC article.
-
Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis.Emerg Infect Dis. 2009 Jul;15(7):1061-7. doi: 10.3201/eid1507.081253. Emerg Infect Dis. 2009. PMID: 19624921 Free PMC article.
-
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.Curr Clin Pharmacol. 2010 May;5(2):96-114. doi: 10.2174/157488410791110797. Curr Clin Pharmacol. 2010. PMID: 20156156 Free PMC article. Review.
-
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions.J Vis Exp. 2017 May 8;(123):55559. doi: 10.3791/55559. J Vis Exp. 2017. PMID: 28518128 Free PMC article.